Patents of Jan Tavernier

KINASE SUBSTRATE SENSOR

Patent application(s)

WO2012117031 ( 06 September 2012 )

Granted patent(s)

EP2681319 ( 13 December 2016 )

THERAPEUTIC TARGETING OF NON-CELLULAR ANTIGENS

Patent application(s)

WO2017194782 ( 15 November 2017 )

TARGETED MUTANT INTERFERON-β USES THEREOF

Patent application(s)

WO2017194783 ( 15 November 2017 )

Granted patent(s)

EP3454887 ( 19 January 2021 )

FIBROBLAST BINDING AGENTS AND USE THEREOF

Patent application(s)

WO2019152979 ( 07 August 2019 )

FMS-like tyrosine kinase 3 ligand (FLT3L)-Based chimeric proteins

Patent application(s)

WO2020198659 ( 30 September 2020 )

COMBINATION THERAPY WITH CD13-TARGETED CHIMERIC PROTEINS OR CHIMERIC PROTEIN COMPLEXES

Patent application(s)

WO2020257412 ( 23 December 2020 )

The use of topoisomerase type I inhibitors to treat viral infections

Patent application(s)

WO2010020676 ( 24 February 2010 )

Anti-cancer therapy using a leptin antagonist and an iNKT-cell activator

Patent application(s)

WO2017207040 ( 06 December 2017 )

Membrane span-kinase fusion protein and the uses thereof

Patent application(s)

WO2013131957 ( 11 September 2013 )

Granted patent(s)

EP2823044 ( 05 December 2017 )

IMMUNOSTIMULATORY ADJUVANTS

Patent application(s)

WO2022011005 ( 12 January 2022 )

MODULATION OF DENDRITIC CELL LINEAGES

Patent application(s)

WO2020097350 ( 13 May 2020 )

TARGETED MUTANT INTERFERON-GAMMA AND USES THEREOF

Patent application(s)

WO2018077893 ( 02 May 2018 )

Granted patent(s)

EP3529264 ( 08 March 2022 )

BI-FUNCTIONAL CHIMERIC PROTEINS AND USES THEREOF

Patent application(s)

WO2017077382 ( 10 May 2017 )

Granted patent(s)

EP3371311 ( 20 July 2021 )

TARGETED CHIMERIC PROTEINS AND USES THEREOF

Patent application(s)

WO2018141964 ( 08 August 2018 )

TARGETED THERAPEUTIC AGENTS AND USES THEREOF

Patent application(s)

WO2017134302 ( 09 August 2017 )

Granted patent(s)

EP3411398 ( 02 April 2024 )

IMMUNE-CELL TARGETED BISPECIFIC CHIMERIC PROTEINS AND USES THEREOF

Patent application(s)

WO2018146074 ( 15 August 2018 )

Granted patent(s)

US11246911 ( 14 February 2022 )

VIRAL PARTICLE BASED SMALL MOLECULE-PROTEIN INTERACTION TRAP

Patent application(s)

WO2016150992 ( 28 September 2016 )

Granted patent(s)

EP3274722 ( 30 August 2022 )

TARGETING OF CYTOKINE ANTAGONISTS

Patent application(s)

WO2015007520 ( 21 January 2015 )

Granted patent(s)

EP3022230 ( 05 November 2019 )

TARGETED MODIFIED IL-1 FAMILY MEMBERS

Patent application(s)

WO2015007542 ( 21 January 2015 )

Granted patent(s)

EP3022226 ( 04 December 2018 )

FUSOKINES INVOLVING CYTOKINES WITH STRONGLY REDUCED RECEPTOR BINDING AFFINITIES

Patent application(s)

WO2015007536 ( 18 March 2015 )

Granted patent(s)

EP3299466 ( 10 September 2019 )

TARGETED MODIFIED TNF FAMILY MEMBERS

Patent application(s)

WO2015007903 ( 21 January 2015 )

Granted patent(s)

EP3021865 ( 12 June 2018 )

CD20 BINDING AGENTS AND USES THEREOF

Patent application(s)

WO2017153345 ( 13 September 2017 )

CD20 BINDING AGENTS

Patent application(s)

WO2017153402 ( 13 September 2017 )

Granted patent(s)

EP3426278 ( 02 January 2024 )

TARGETED MUTANT ALPHA-HELICAL BUNDLE CYTOKINES

Patent application(s)

WO2013107791 ( 24 July 2013 )

Granted patent(s)

EP2804877 ( 21 August 2018 )

BISPECIFIC SIGNALING AGENT AND USES THEREOF

Patent application(s)

WO2017134305 ( 09 August 2017 )

CD8 BINDING AGENTS

Patent application(s)

WO2017134306 ( 09 August 2017 )

Granted patent(s)

US11236166 ( 31 January 2022 )

CLEC9A BINDING AGENTS AND USE THEREOF

Patent application(s)

WO2017134301 ( 09 August 2017 )

Granted patent(s)

EP3411065 ( 30 March 2021 )

Viral particle based protein-protein interaction trap

Patent application(s)

WO2013174999 ( 27 November 2013 )

Granted patent(s)

US11237174 ( 31 January 2022 )